Free Trial
TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

Resverlogix logo
C$0.04 +0.01 (+12.50%)
As of 03/28/2025 03:57 PM Eastern

About Resverlogix Stock (TSE:RVX)

Key Stats

Today's Range
C$0.05
C$0.05
50-Day Range
C$0.04
C$0.06
52-Week Range
C$0.04
C$0.10
Volume
3,000 shs
Average Volume
48,032 shs
Market Capitalization
C$8.91 million
P/E Ratio
N/A
Dividend Yield
7.02%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Remove Ads
Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

RVX Stock News Headlines

Elon’s ‘Strike Squad’ sends these 9 stocks soaring?
Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the federal government. And that's creating a huge buying opportunity for the stocks involved. Put simply, under Elon's watchful eye, the U.S. government is rapidly adopting AI technology. And that's sending certain stocks soaring higher.
Resverlogix Corp. (RVXCF)
Closing Bell: Resverlogix Corp up on Tuesday (RVX)
Closing Bell: Resverlogix Corp flat on Wednesday (RVX)
See More Headlines

RVX Stock Analysis - Frequently Asked Questions

Resverlogix's stock was trading at C$0.06 at the start of the year. Since then, RVX shares have decreased by 18.2% and is now trading at C$0.05.
View the best growth stocks for 2025 here
.

Resverlogix Corp. (TSE:RVX) released its quarterly earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.03) earnings per share for the quarter.

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resverlogix investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), Oncolytics Biotech (ONC), Radient Technologies (RTI), VentriPoint Diagnostics (VPT) and Burcon NutraScience (BU).

Company Calendar

Last Earnings
11/12/2024
Today
3/30/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:RVX
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,808,530.87
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
132.50
Book Value
C($0.23) per share
Price / Book
-0.19

Miscellaneous

Free Float
N/A
Market Cap
C$8.91 million
Optionable
Not Optionable
Beta
0.71
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (TSE:RVX) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners